Merck KGaA forecast lackluster earnings in guidance that reflects generic competition for its multiple sclerosis blockbuster drug Mavenclad, but not the potential benefits from the US launch of a ...

Inhaled corticosteroid–long-acting beta-agonist (ICS-LABA) inhalers are widely prescribed for asthma and chronic obstructive pulmonary disease. ICS-LABAs are largely interchangeable within the class; ...

Dr Reddy’s Laboratories Ltd. is planning to launch a generic version of Ozempic in March after Novo Nordisk AS's patent for the drug expires. That would make the Indian drugmaker one of the first ...

TORONTO - Drug companies in Canada are allowed to make lower priced generic versions of the blockbuster drug Ozempic as of next week, but experts say patients shouldn’t expect it to be available for ...

In 2026, Novo Nordisk’s patent on semaglutide will expire in several countries, including India and China. Generic-drug makers are poised to flood these markets with inexpensive products. Industry ...

Prescription drugs aren't optional, but the cost often feels like it is stacked against you. Whether you take daily medications for blood pressure, cholesterol, or thyroid health, the bills can add up ...

One of the world’s most sought-after drugs has officially become a vital medication. The World Health Organization has just added semaglutide—the active ingredient in Ozempic and Wegovy—to its list of ...

Community driven content discussing all aspects of software development from DevOps to design patterns. Software development is one of the most rewarding careers in the world of IT. Java is one of the ...

President Donald Trump’s promise to impose tariffs on pharmaceutical imports is raising red flags among generic drugmakers and industry experts, who warn that such a move could lead to increased drug ...